In a drug industry where accurate timelines are crucial, the perception that the FDA is becoming arbitrary and gameable is bad for business, or at least for clarity.
In November, what was supposed to be a marquee announcement of lower prices for the blockbuster weight-loss drugs from Novo Nordisk A/S and Eli Lilly & Co. went viral for the wrong reason: An onlooker collapsed in the Oval Office, and it was captured… [752 chars]
Source: Bloomberg | Published: 2026-02-09T14:00:07Z
Credit: Bloomberg
